Stay updated with breaking news from Ross ellenhorn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
With increasing legislation and attention from a diverse range of lawmakers and experts, psychedelics could receive regulatory clarity to help the market expand further. ....
In today’s newsletter: They’re climbing bridges, clogging traffic and vandalising a Van Gogh. But are protesters on the right road to a climate revolution – and how far will the government go to stop them? ....
Illustration by Sandra Dionisi for Rolling Stone In 2002, Dimitri M. was ready to die. He’d been addicted to heroin for over 20 years, and his once-promising artistic life had collapsed into a series of banal pit stops: from the methadone clinic, to the valet parking gig, to the coke dealer, to the dope dealer, to the bed, and over and over again. Eventually, his longtime partner succumbed to intravenous drug use, and, though they were married by common law, he was barred from attending her funeral. Dimitri was ready to finally let the drugs carry him away, like an undertow. He planned to take a trip to Greece as a last goodbye to his ancestral homeland, but while researching his farewell voyage, he was reminded of a conversation with an old friend about a hallucinogenic plant with the purported power to heal opioid addiction. He embarked on his trip as planned, but scheduled a brief detour in the Netherlands to be treated with this so-called miracle drug: Ibogain ....
comments Supposedly, we are living through a psychedelic renaissance. From ketamine antidepressants to MDMA-assisted psychotherapy, the medical use of psychedelic drugs is portrayed in the media as a boon for the mental health profession, which reports seemingly miraculous results for treating some of the most significant mental health issues facing our time. The FDA has granted breakthrough status for both psilocybin and MDMA as treatments, and venture capitalists are placing bets on psychedelics to curb the trillion dollar public health burden. As psychedelic advocates and practitioners with decades of experience, having worked with thousands of people, we believe we need a serious examination of whether the current mental health industry is the place for psychedelic drugs. Looking at the industry historically, there have been repeated claims of breakthrough modalities that would bring psychiatry into the realm of medical science. Yet none of these claims have demons ....